JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Monoclonal antibody therapy and other Biological Modalities

Includes

Systemic treatment with monoclonal antibody (MAb) treatments

Obligatory

Must not donate

Discretionary

a) If an individual monoclonal antibody treatment is listed in the entry for the underlying condition, apply guidance as per that entry.
 

b) If the underlying condition does not preclude donation, and it is more than 6 months from last treatment, accept.

See

Is there is a specific A-Z index entry for the treatment and/or condition you are concerned about?

See if Relevant

Autoimmune Disease
Clinical Trials
Eye Disease
Hypercholesterolemia
Osteopenia

Additional Information

Current scientific literature does not provide conclusive evidence to reject concerns that individuals on these treatments are more prone to infection. Until further clarity is provided in the literature, donors on these medications are withdrawn, unless otherwise stated.

Reason for change

This is a new entry.

Update Information

This entry was last updated in:
WB-DSG Edition 203 Release 71